Table 1.
Descriptive Analysis of the Cancer and Control Groups
| Group Control (n = 37) Group Cancer (n = 36) | |||||
|---|---|---|---|---|---|
| Gender | |||||
| Male | 15 | 33.33% | 24 | 66.67% | p=0.01 |
| Female | 22 | 66.67% | 12 | 33.33% | |
| Age | |||||
| (mean +/- SD) | 58.24 | (14,49) | 61.69 | (12,27) | p=0.13 |
| Max | 84 | 85 | |||
| Min | 28 | 36 | |||
| BMI | |||||
| Underweight | 2 | 5.56% | |||
| Normal weight | 21 | 58.33% | |||
| Overweight | 13 | 36.11% | |||
| Location of the tumor | |||||
| Colon right | 4 | 11.11% | |||
| Colon left | 32 | 88.89% | |||
| Degree of differentiation | |||||
| Well-differentiated | 10 | 27.78% | |||
| Moderately differentiated | 16 | 44.44% | |||
| Poorly differentiated | 10 | 27.78% | |||
| Metastasis | |||||
| Regional lymph nodes | 6 | 16.67% | |||
| Distant | 24 | 66.67% | |||
| Without metastasis | 6 | 16.70% | |||
| Pretreatment | |||||
| Without pretreatment | 17 | 47.22% | |||
| QT e/ou RT | 19 | 52.78% | |||